Advertisement

Topics

Bounty of New HCC Therapies Spurs Need for More Research

13:24 EDT 10 May 2019 | OncLive

The optimal integration of new drugs into the treatment paradigm of HCC requires several key developments, including greater research into biomarkers that would help inform therapy choices, earlier treatment for patients diagnosed with HCC, and clinical trials that test combination strategies.

Original Article: Bounty of New HCC Therapies Spurs Need for More Research

NEXT ARTICLE

More From BioPortfolio on "Bounty of New HCC Therapies Spurs Need for More Research"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...